Procter & Gamble Health Limited announced that Dr. Elizabeth Desmond, Non-Executive Director has tendered her resignation as the Director of the Company effective close of business hours of March 31, 2023. Further Board of Directors of the Company, at its meeting held March 17, 2023, have appointed Ms. Seema Sambasivan as an Additional (Non- Executive) Director of the Company with effect April 1, 2023, subject to allotment of Director
Identification Number by the Ministry of Corporate Affairs. Ms. Sambasivan will hold office as Additional Director up to the ensuing Annual General Meeting. Ms. Seema Sambasivan has completed her MSc in Microbiology from University of Mumbai. She completed her education in India, after which she joined P&G and subsequently moved to Singapore. She has worked with Procter & Gamble for over 25 years and has specialized in the Health care category throughout her time there. She is currently the Senior Director for Personal Health Care ­ Global Product Stewardship across Africa, Middle East, AsiaPacific and China. Over the last 18 years, Ms. Sambasivan has focussed on Regulatory Affairs under the Global Product Stewardship discipline. She leads the Regulatory Affairs Team for Africa, Middle East, AsiaPacific and China delivering compliance strategies for Base Business and Innovation. Her experience encompasses a wide range of regulatory classifications including medicines, medical devices, electronic devices, supplements, food and cosmetics across diverse categories including Respiratory, Nerve Care, Anaemia, Energy & muscle health, General Health, Digestive Wellness and Oral Care.